Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Rutkowski, Piotr ^a   Wozniak, Agnieszka ^b   Switaj, Tomasz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SURAMIN;

ADVANCED CANCER; ANEMIA; CANCER SURVIVAL; CHROMOSOME REARRANGEMENT; DERMATOFIBROSARCOMA PROTUBERANS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; EDEMA; FATIGUE; FLUID RETENTION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DOSAGE; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSFECTION; HUMAN; INOPERABLE CANCER; METASTASIS; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; MULTIPLEX POLYMERASE CHAIN REACTION; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME; UPREGULATION; VOMITING;

EID: 79959311105     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/959132     Document Type: Review

References (60)

1. Chang C. K., Jacobs I. A., Salti G. I., Outcomes of surgery for dermatofibrosarcoma protuberans European Journal of Surgical Oncology 2004 30 3 341 345 (Pubitemid 38425655)
2. Laskin W. B., Dermatofibrosarcoma protuberans CA: A Cancer Journal for Clinicians 1992 42 2 116 125
3. Bowne W. B., Antonescu C. R., Leung D. H. Y., Katz S. C., Hawkins W. G., Woodruff J. M., Brennan M. F., Lewis J. J., Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution Cancer 2000 88 12 2711 2720 (Pubitemid 30417931)
4. Mentzel T., Beham A., Katenkamp D., Dei Tos A. P., Fletcher C. D. M., Fibrosarcomatous (high-grade) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance American Journal of Surgical Pathology 1998 22 5 576 587 (Pubitemid 28213745)
5. Lal P., Sharma R., Mohan H., Sekhon M. S., Dermatofibrosarcoma protuberans metastasizing to lymph nodes: a case report and review of literature Journal of Surgical Oncology 1999 72 3 178 180
6. Diaz-Cascajo C., Weyers W., Bornego L., Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemical study four cases American Journal of Dermathopathology 1997 19 562 567 (Pubitemid 27512405)
7. Kimmel Z., Ratner D., Kim J. Y. S., Wayne J. D., Rademaker A. W., Alam M., Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data Annals of Surgical Oncology 2007 14 7 2113 2120 (Pubitemid 46988248)
8. Gloster H. M., Harris K. R., Roenigk R. K., A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans Journal of the American Academy of Dermatology 1996 35 1 82 87 (Pubitemid 26231329)
9. Barnes L., Coleman J. A. Jr., Johnson J. T., Dermatofibrosarcoma protuberans of the head and neck Archives of Otolaryngology 1984 110 6 398 404 (Pubitemid 14109491)
10. Roses D. F., Valensi Q., LaTrenta G., Harris M. N., Surgical treatment of dermatofibrosarcoma protuberans Surgery Gynecology and Obstetrics 1986 162 5 449 452 (Pubitemid 16026861)
11. Th. Rutgers E.J. E. J., Kroon B. B. R., Albus-Lutter C. E., Gortzak E., Dermatofibrosarcoma protuberans: treatment and prognosis European Journal of Surgical Oncology 1992 18 3 241 248
12. Koh C. K., Ko C. B., Bury H. P. R., Wyatt E. H., Dermatofibrosarcoma protuberans International Journal of Dermatology 1995 34 4 256 260
13. Stojadinovic A., Karpoff H. M., Antonescu C. R., Shah J. P., Singh B., Spiro R. H., Dumornay W., Shaha A. R., Dermatofibrosarcoma protuberans of mthe head and neck Annals of Surgical Oncology 2000 7 9 696 704
14. Heuvel S. T., Suurmeijer A., Pras E., Van Ginkel R. J., Hoekstra H. J., Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins European Journal of Surgical Oncology 2010 36 1 89 94
15. Fiore M., Miceli R., Mussi C., Lo Vullo S., Mariani L., Lozza L., Collini P., Olmi P., Casali P. G., Gronchi A., Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate Journal of Clinical Oncology 2005 23 30 7669 7675 (Pubitemid 46291832)
16. DuBay D., Cimmino V., Lowe L., Johnson T. M., Sondak V. K., Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution Cancer 2004 100 5 1008 1016 (Pubitemid 38222862)
17. Farma J. M., Ammori J. B., Zager J. S., Marzban S. S., Bui M. M., Bichakjian C. K., Johnson T. M., Lowe L., Sabel M. S., Wong S. L., Douglas Letson G., Messina J. L., Cimmino V. M., Sondak V. K., Dermatofibrosarcoma protuberans: how wide should we resect? Annals of Surgical Oncology 2010 17 2112 2118
18. Wacker J., Khan-Durani B., Hartschuh W., Modified mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients Annals of Surgical Oncology 2004 11 4 438 444 (Pubitemid 40486756)
19. Khatri V. P., Galante J. M., Bold R. J., Schneider P. D., Ramsamooj R., Goodnight J. E., Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment Annals of Surgical Oncology 2003 10 9 1118 1122 (Pubitemid 40486838)
20. Meguerditchian A. N., Wang J., Lema B., Kraybill W. G., Zeitouni N. C., Kane J. M., Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans American Journal of Clinical Oncology 2010 33 3 300 303
21. Bridge J. A., Neff J. R., Sandberg A. A., Cytogenetic analysis of dermatofibrosarcoma protuberans Cancer Genetics and Cytogenetics 1990 49 2 199 202 (Pubitemid 20372134)
22. Mandahl N., Heim S., Willen H., Rydholm A., Mitelman F., Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans Cancer Genetics and Cytogenetics 1990 49 2 273 275 (Pubitemid 20372145)
23. Mandahl N., Limon J., Mertens F., Arheden K., Mitelman F., Ring marker containing 17q and chromosome 22 in a case of dermatofibrosarcoma protuberans Cancer Genetics and Cytogenetics 1996 89 1 88 91
24. Pedeutour F., Coindre J. M., Sozzi G., Nicolo G., Leroux A., Toma S., Miozzo M., Bouchot C., Hecht F., Ayraud N., Turc-Carel C., Supernumerary ring chromosomes containing chromosome 17 sequences: a specific feature of dermatofibrosarcoma protuberans? Cancer Genetics and Cytogenetics 1994 76 1 1 9 (Pubitemid 24280174)
25. Pedeutour F., Simon M. P., Minoletti F., Sozzi G., Pierotti M. A., Hecht F., Turc-Carel C., Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences Cancer Research 1995 55 11 2400 2403
26. Pedeutour F., Lacour J. P., Perrin C., Huffermann K., Simon M. P., Ayraud N., Turc-Carel C., Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans Cancer Genetics and Cytogenetics 1996 89 2 175 176 (Pubitemid 26286760)
27. Pedeutour F., Simon M. P., Minoletti F., Barcelo G., Terrier-Lacombe M. J., Combemale P., Sozzi G., Ayraud N., Turc-Carel C., Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement Cytogenetics and Cell Genetics 1996 72 2-3 171 174 (Pubitemid 26080105)
28. Kiuru-Kuhlefelt S., El-Rifai W., Fanburg-Smith J., Kere J., Miettinen M., Knuutila S., Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans Cytogenetics and Cell Genetics 2001 92 3-4 192 195 (Pubitemid 32641992)
29. Linn S. C., West R. B., Pollack J. R., Zhu S., Hernandez-Boussard T., Nielsen T. O., Rubin B. P., Patel R., Goldblum J. R., Siegmund D., Botstein D., Brown P. O., Gilks C. B., Van De Rijn M., Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans American Journal of Pathology 2003 163 6 2383 2395 (Pubitemid 37466479)
30. Sandberg A. A., Bridge J. A., Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: dermatofibrosarcoma protuberans and giant cell fibroblastoma Cancer Genetics and Cytogenetics 2003 140 1 1 12 (Pubitemid 36110633)
31. Sirvent N., Maire G., Pedeutour F., Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment Genes Chromosomes and Cancer 2003 37 1 1 19 (Pubitemid 36417917)
32. Simon M. P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F., Coindre J. M., Terrier-Lacombe M. J., Mandahl N., Craver R. D., Blin N., Sozzi G., Turc-Carel C., O'Brien K. P., Kedra D., Fransson I., Guilbaud C., Dumanski J. P., Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma Nature Genetics 1997 15 1 95 98 (Pubitemid 27014958)
33. Shimizu A., O'Brien K. P., Sjblom T., Pietras K., Buchdunger E., Collins V. P., Heldin C. H., Dumanski J. P., stman A., The dermatofibrosarcoma protuberans-associated collagen type I 1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB Cancer Research 1999 59 15 3719 3723 (Pubitemid 29381878)
34. Simon M.-P., Navarro M., Roux D., Transforming properties of chimerical protein COL1A1-PDGFB generated by dermatofibrosarcoma protuberans-associated translocation t(17;22)(q22;q13.1) Cancer Genetics and Cytogenetics 2001 128 82
35. McArthur G., Molecularly targeted treatment for dermatofibrosarcoma protuberans Seminars in Oncology 2004 31 6 30 36 (Pubitemid 38879420)
36. Greco A., Fusetti L., Villa R., Sozzi G., Minoletti F., Mauri P., Pierotti M. A., Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans Oncogene 1998 17 10 1313 1319 (Pubitemid 28446172)
37. Greco A., Roccato E., Miranda C., Cleris L., Formelli F., Pierotti M. A., Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement International Journal of Cancer 2001 92 3 354 360 (Pubitemid 32249711)
38. Dal Cin P., Sciot R., De Wever I., Brock P., Casteels-Van Daele M., Van Damme B., Van Den Berghe H., Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans Genes Chromosomes and Cancer 1996 15 1 73 75 (Pubitemid 26018460)
39. O'Brien K. P., Seroussi E., Dal Cin P., Sciot R., Mandahl N., Fletcher J. A., Turc-Carel C., Dumanski J. P., Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant- cell fibroblastomas Genes Chromosomes and Cancer 1998 23 2 187 193 (Pubitemid 28402346)
40. Terrier-Lacombe M. J., Guillou L., Maire G., Terrier P., Vince D. R., Somerhausen N. D. S. A., Collin F., Pedeutour F., Coindre J. M., Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular dataa study from the french federation of cancer centers sarcoma group American Journal of Surgical Pathology 2003 27 1 27 39 (Pubitemid 36014896)
41. Macarenco R. S., Zamolyi R., Franco M. F., Nascimento A. G., Abott J. J., Wang X., Erickson-Johnson M. R., Oliveira A. M., Genomic gains of COLIAI-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans Genes Chromosomes and Cancer 2008 47 3 260 265 (Pubitemid 351162857)
42. Abbott J. J., Erickson-Johnson M., Wang X., Nascimento A. G., Oliveira A. M., Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans Modern Pathology 2006 19 11 1512 1518 (Pubitemid 44624172)
43. Kerob D., Pedeutour F., Leboeuf C., Verola O., De Kerviler E., Servant J. M., Sarandi F., Bousquet G., Madelaine-Chambrin I., Pruvost C., Calvo F., Janin A., Lebbe C., Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans Journal of Clinical Oncology 2008 26 10 1757 1759
44. Wang J., Morimitsu Y., Okamoto S., Hisaoka M., Ishida T., Sheng W., Hashimoto H., COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans Journal of Molecular Diagnostics 2000 2 1 47 52
45. Patel K. U., Szabo S. S., Hernandez V. S., Prieto V. G., Abruzzo L. V., Lazar A. J. F., Lpez-Terrada D., Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays Human Pathology 2008 39 2 184 193
46. Sjblom T., Shimizu A., O'Brien K. P., Pietras K., Dal Cin P., Buchdunger E., Dumanski J. P., stman A., Heldin C. H., Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis Cancer Research 2001 61 15 5778 5783 (Pubitemid 32769094)
47. Maki R. G., Awan R. A., Dixon R. H., Jhanwar S., Antonescu C. R., Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans International Journal of Cancer 2002 100 6 623 626 (Pubitemid 34832970)
48. Rubin B. P., Schuetze S. M., Eary J. F., Norwood T. H., Mirza S., Conrad E. U., Bruckner J. D., Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans Journal of Clinical Oncology 2002 20 17 3586 3591 (Pubitemid 34983217)
49. Pedeutour F., Coindre J. M., Nicolo G., Response of metastatic dermatofibrosarcoma protuberans to imatinib mesylate Proceedings of the American Society of Clinical Oncology 2003 23, abstract 3334
50. Ruka W., Falkowski S., Grzesiakowska U., The partial response of lung metastases arising from dermatofibrosarcoma protuberans after one month of imatinib mesylate therapya case report Nowotwory 2003 53 2 165 168 (Pubitemid 36604183)
51. Labropoulos S. V., Fletcher J. A., Oliveira A. M., Papadopoulos S., Razis E. D., Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate Anti-Cancer Drugs 2005 16 4 461 466 (Pubitemid 40434613)
52. Mizutani K., Tamada Y., Hara K., Tsuzuki T., Saeki H., Tamaki K., Matsumoto Y., Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans British Journal of Dermatology 2004 151 1 235 237 (Pubitemid 39061309)
53. McArthur G. A., Demetri G. D., Van Oosterom A., Heinrich M. C., Debiec-Rychter M., Corless C. L., Nikolova Z., Dimitrijevic S., Fletcher J. A., Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B2225 Journal of Clinical Oncology 2005 23 4 866 873 (Pubitemid 46224187)
54. Heinrich M. C., Joensuu H., Demetri G. D., Corless C. L., Apperley J., Fletcher J. A., Soulieres D., Dirnhofer S., Harlow A., Town A., McKinley A., Supple S. G., Seymour J., Di Scala L., Van Oosterom A., Herrmann R., Nikolova Z., McArthur G., Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib- sensitivetyrosine kinases Clinical Cancer Research 2008 14 9 2717 2725
55. Rutkowski P., Van Glabbeke M., Rankin C. J., Ruka W., Rubin B. P., Debiec-Rychter M., Lazar A., Gelderblom H., Sciot R., Lopez-Terrada D., Hohenberger P., van Oosterom A. T., Schuetze S. M., Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials Journal of Clinical Oncology 2010 28 10 1772 1779
56. Rutkowski P., Dbiec-Rychter M., Nowecki Z. I., Michej W., Symonides M., Ptaszynski K., Ruka W., Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection Journal of the European Academy of Dermatology and Venereology 2011 25 3 264 270
57. Gronchi A., Stacchiotti S., Pedeutour F., Response to imatinib mesylate (IM) in fibrosarcoma (FS) arising in dermatofibrosarcoma protuberans (DFSP) Journal of Clinical Oncology 2008 26, supplement. abstract 10593
58. Krob D., Porcher R., Vrola O., Dalle S., Maubec E., Aubin F., D'Incan M., Bodokh I., Boulinguez S., Madelaine-Chambrin I., Mathieu-Boue A., Servant J. M., De Kerviler E., Janin A., Calvo F., Pedeutour F., Lebbe C., Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients Clinical Cancer Research 2010 16 12 3288 3295
59. West R. B., Rubin B. P., Miller M. A., Subramanian S., Kaygusuz G., Montgomery K., Zhu S., Marinelli R. J., De Luca A., Downs-Kelly E., Goldblum J. R., Corless C. L., Brown P. O., Gilks C. B., Nielsen T. O., Huntsman D., Van De Rijn M., A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 3 690 695 (Pubitemid 43153087)
60. Blay J. Y., El Sayadi H., Thiesse P., Garret J., Ray-Coquard I., Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT) Annals of Oncology 2008 19 4 821 822 (Pubitemid 351461057)